1
/
of
3
GLOW 50/10/10mg – 10 Vial Box
GLOW 50/10/10mg – 10 Vial Box
Regular price
$448.00 USD
Regular price
Sale price
$448.00 USD
Description
Description
GLOW 50/10/10 is a multi-compound peptide blend consisting of GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg), formulated for research examining overlapping tissue remodeling and cellular signaling pathways.
- GHK-Cu is a copper-binding tripeptide investigated for its interactions with extracellular matrix remodeling, inflammatory cytokine expression, angiogenic signaling, and collagen synthesis regulation.
- TB-500 (TB-4) is a synthetic Thymosin Beta-4 analogue studied for its interactions with actin sequestration, fibroblast migration, and extracellular matrix reorganization across muscle, tendon, and ligament tissue models.
- BPC-157 is a naturally occurring peptide studied for its observed effects on fibroblast proliferation, gastrointestinal epithelial integrity, tendon extracellular matrix remodeling, and inflammatory marker modulation.
These compounds are investigated in combination for their complementary mechanistic profiles across overlapping extracellular matrix, angiogenic, and inflammatory signaling pathways.
For Research Use Only. Not for Human Consumption.
Minimum order quantity: one box (10 vials x 70 mg, 700 mg of peptides in total).
Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.
Specifications
Additional information
| Purity |
≥99.0% |
|---|---|
| Cost per vial $ |
56 |
Research
- Malinda, Katherine M., et al. "Thymosin β4 accelerates wound healing." Journal of Investigative Dermatology 113.3 (1999): 364-368.
- Cheng, Peng, et al. "Beneficial effects of thymosin β4 on spinal cord injury in the rat." Neuropharmacology 85 (2014): 408-416.
- Dubé, Karina N., and Nicola Smart. "Thymosin β4 and the vasculature: multiple roles in development, repair and protection against disease." Expert opinion on biological therapy 18.sup1 (2018): 131-139.
- Song, Ran, et al. "Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy." Clinical rheumatology 31 (2012): 1253-1258.
- Philp, D., A. L. Goldstein, and H. K. Kleinman. "Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development." Mechanisms of ageing and development 125.2 (2004): 113-115.
- Seiwerth, Sven, et al. "BPC 157's effect on healing." Journal of Physiology-Paris 91.3-5 (1997): 173-178.
- Huang, Tonglie, et al. "Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro." Drug design, development and therapy (2015): 2485-2499.
- Chang, Chung-Hsun, et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." Journal of applied physiology 110.3 (2011): 774-780.
- Pickart, Loren, and Anna Margolina. "Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data." International journal of molecular sciences 19.7 (2018): 1987.
- Pickart, Loren, Jessica Michelle Vasquez-Soltero, and Anna Margolina. "The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health." Oxidative medicine and cellular longevity 2012 (2012).
Testing Docs
Product features
Product features
Materials and care
Materials and care
Merchandising tips
Merchandising tips
Share
